World's Best Scientists 2026 revealed!
Christine J. Harrison

Christine J. Harrison

D-Index & Metrics

Biology and Biochemistry

D-Index
91
Citations
36228
World Ranking
2291
National Ranking
155

Medicine

D-Index
92
Citations
36876
World Ranking
11174
National Ranking
1062

Overview

Christine J. Harrison is affiliated with Newcastle University in the United Kingdom and has a research focus predominantly situated within the field of Medicine, with significant contributions to Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Pediatrics, Perinatology and Child Health, and Genetics.

Their research topics cover various aspects of leukemia and cancer, including Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Childhood Cancer Survivors' Quality of Life, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, and Cancer Genomics and Diagnostics.

Christine J. Harrison's recent publications include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms, 2022, Leukemia
  • Acute lymphoblastic leukaemia, 2024, Nature Reviews Disease Primers
  • Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge, 2021, Genes
  • HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions, 2021, Leukemia
  • Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study, 2021, Leukemia

The scientist commonly collaborates with several frequent co-authors, including Anthony V. Moorman, Claire Schwab, Amir Enshaei, Ajay Vora, and Sarra Ryan.

Christine J. Harrison's research is published across multiple scientific venues with multiple contributions, particularly in:

  • Blood (17 publications)
  • Leukemia (13 publications)
  • British Journal of Haematology (5 publications)
  • Journal of Clinical Oncology (4 publications)
  • Blood Advances (3 publications)

Best Publications

  • The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

    David Grimwade;Helen Walker;Fiona Oliver;Keith Wheatley

  • Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    David Grimwade;Robert K. Hills;Anthony V. Moorman;Helen Walker

  • The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

    David Grimwade;Helen Walker;Georgina Harrison;Fiona Oliver

  • Burkitt's lymphoma

    Elizabeth M Molyneux;Rosemary Rochford;Beverly Griffin;Robert Newton

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

    Lisa J. Russell;Melania Capasso;Inga Vater;Takashi Akasaka

  • A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.

    Keith Wheatley;Alan Kenneth Burnett;Anthony H. Goldstone;Richard G. Gray

  • Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

    Anthony V Moorman;Hannah M Ensor;Sue M Richards;Lucy Chilton

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

    Chirstine J. Harrison;Robert Kerrin Hills;Anthony V. Moorman;David J. Grimwade

  • PHF6 mutations in T-cell acute lymphoblastic leukemia

    Pieter van Vlierberghe;Pieter van Vlierberghe;Pieter van Vlierberghe;Teresa Palomero;Hossein Khiabanian;Joni van der Meulen

  • Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.

    B E S Gibson;K Wheatley;I M Hann;R F Stevens

  • Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia

    James B. Nachman;Nyla A. Heerema;Harland Sather;Bruce Camitta

  • Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique

    Lia P Menasce;Gavin R M White;Christine J Harrison;John M Boyle

  • Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

    Arian van der Veer;Esmé Waanders;Rob Pieters;Marieke E. Willemse

  • Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

    Amy L. Sherborne;Fay J. Hosking;Rashmi B. Prasad;Rajiv Kumar

  • Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

    Libi Hertzberg;Libi Hertzberg;Libi Hertzberg;Elena Vendramini;Ithamar Ganmore;Ithamar Ganmore;Giovanni Cazzaniga

  • Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

    CH Pui;JM Chessells;B Camitta;A Baruchel

  • Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

    Yilong Li;Claire Schwab;Sarra L. Ryan;Elli Papaemmanuil

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Anthony V. Moorman
Anthony V. Moorman Newcastle University
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Mel Greaves
Mel Greaves Institute of Cancer Research
Martin Stanulla
Martin Stanulla Hannover Medical School
Oskar A. Haas
Oskar A. Haas Medical University of Vienna
Hélène Cavé
Hélène Cavé Université Paris Cité
Jochen Harbott
Jochen Harbott University of Giessen
Giovanni Cazzaniga
Giovanni Cazzaniga University of Milano-Bicocca
Rob Pieters
Rob Pieters Princess Máxima Center
Henrik Hasle
Henrik Hasle Aarhus University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Christine J. Harrison

Trending Scientists

Recently Published Articles